Document Detail


Pediatric sepsis: actions to decrease sepsis in children.
MedLine Citation:
PMID:  19803702     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The European Society of Pediatric and Neonatal Intensive Care is the physicians' and nurses' annual meeting that was held in Verona, Italy from 14 to 17 June 2009, and approximately 1000 participants from around the world (84 countries) attended. The Congress gave an opportunity to experts to discuss ongoing research and exchange opinions on the future development of studies to identify optimal supportive, preventive and therapeutic strategies for sepsis. A wide range of topics were discussed and several lectures, oral presentations and posters were dedicated to sepsis and its treatment. High scientific-level topics were presented, and stimulated much interest and discussion.
Authors:
Giuseppe A Marraro
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Expert review of anti-infective therapy     Volume:  7     ISSN:  1744-8336     ISO Abbreviation:  Expert Rev Anti Infect Ther     Publication Date:  2009 Oct 
Date Detail:
Created Date:  2009-10-06     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101181284     Medline TA:  Expert Rev Anti Infect Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  941-4     Citation Subset:  IM    
Affiliation:
Anesthesia and Intensive Care Department & Pediatric Intensive Care Unit, Fatebenefratelli and Ophthalmiatric Hospital, University of Milan, Milan, Italy. gmarraro@picu.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Child, Preschool
Congresses as Topic
Humans
Infant
Infant, Newborn
Pediatrics*
Sepsis* / diagnosis,  drug therapy,  epidemiology,  therapy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  27th Annual Meeting of the European Society for Paediatric Infectious Diseases.
Next Document:  Current challenges in viral hepatitis, antimicrobial resistance and the influenza pandemic.